Beige Ltd., an affiliate of ChrysCapital, is looking to sell a portion of its stake in Mankind Pharma Ltd. through block deals. As per a term sheet reviewed by Mint, Beige Ltd. is offering to sell up to 11.63 million...
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to $1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease. The maker of hit...
IFF to sell pharma unit to France’s Roquette in $2.85 bln deal
International Flavors & Fragrances said on Tuesday it would sell its pharma solutions business to French plant-based ingredients maker Roquette in a deal valued at $2.85 billion, as it looks to focus on higher...
Walgreens CEO says no plans to sell specialty pharmacy unit
Walgreens Boots Alliance’s CEO rejected a media report, saying the company does not plan to sell specialty pharmacy unit Shields Health Solutions at least for now The pharmacy chain is instead looking for ways to...
Suven Pharma, Cohance Lifesciences to merge to bolster CDMO business
Suven Pharmaceuticals Ltd and Cohance Lifesciences Ltd signed a definitive agreement to merge their businesses, which will further strengthen the former’s position in the contract development and manufacturing...
KKR considers selling stake in India’s $3 billion JB Pharma
KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US...
Sun Pharma to acquire 16.33 pc stake in Surgimatix for USD 3.05 mn
Sun Pharmaceutical Industries Ltd said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is engaged in the business of developing a...
ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
Homegrown private equity fund ChrysCapital is close to acquiring 5-6% stake in pharmaceutical company La Renon Healthcare via secondary sale of shares at an estimated valuation of ₹6,500 crore, or $800 million, multiple...
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the company said late on...
India’s Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
India’s Sun Pharmaceutical Industries Limited said on Wednesday it would buy all the shares of Taro Pharmaceutical Industries it does not already own for $43 per share in cash, effectively taking full control of...
Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share
Sun Pharmaceutical Industries said it has revised upwards the price at which it proposed to fully acquire Israel-based Taro Pharmaceutical Industries to USD 43 per share in cash. In May this year, the company announced...
AstraZeneca Pharma India plans to sell Bengaluru plant
AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of the global manufacturing and supply network by its parent, according to a regulatory filing. The company...